Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $372.2200 (-0.31%) ($372.2200 - $372.2200) on Thu. Dec. 12, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.68% (three month average) | RSI | 71 | Latest Price | $372.2200(-0.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 0.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(47%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.84% in a week (0% probabilities). VIXM(-24%) VXX(-10%) TLT(-5%) TIP(-1%) IGOV(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.84% (StdDev 1.68%) | Hourly BBV | -0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $370.13(0.56%) | 10 Day Moving Average | $369.34(0.78%) | 20 Day Moving Average | $361.58(2.94%) | To recent high | -0.3% | To recent low | 36.2% | Market Cap | $39.466b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |